Skip to main content
Premium Trial:

Request an Annual Quote

Alfa Wasserman, Pressure Bio to Develop Sample-Prep Tools for Low-Abundance Proteins

NEW YORK (GenomeWeb News) — Alfa Wasserman Proteomic Technologies and Pressure BioSciences plan to jointly develop sample-preparation methodologies that can enrich low-abundance proteins and subcellular organelles, AWPT said today.
 
Under the agreement, AWPT will develop cell disruption techniques for sample preparation by using Pressure Bio’s pressure cycling technology, which uses hydrostatic pressure to control biomolecular reactions.
 
AWPT will use the sample-prep system on a broad range of cells and tissues in conjunction with its own Promatix technology, which fractionates organelles and sub-cellular moieties.
 
Financial terms of the agreement were not released.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.